PARIS & SAN FRANCISCO--(BUSINESS WIRE)--SpineGuard (FR0011464452 – ALSGD), a fast-growing company that develops and markets disposable medical devices designed to make spine surgery safer, today announced the addition of an experienced spine industry executive to the company’s senior management team.
Steve McAdoo has joined SpineGuard as Vice President of Business Development with the global responsibility for driving industry partnerships to further leverage the company’s core technology, Dynamic Surgical Guidance (DSG™); deploy new applications and initiate new revenue streams. Mr. McAdoo has over 27 years of global marketing, sales management and business development experience in the medical device industry, including spine, general orthopedics, trauma, cardio-vascular and urology. Over the course of his career, he held roles in large corporations such as Medtronic, Smith & Nephew, and Biomet as well as in start-up companies like Danek Medical, Cerapedics, and SURx.
Pierre Jérôme, CEO and co-founder of SpineGuard, said: “We are delighted to welcome Steve on board at this very exciting stage of SpineGuard’s development where we have tremendous opportunities ahead of us. I am confident that his deep and broad medical device industry experience will help us capitalize on our current great momentum and rapidly expand the scope of our business.”
Steve McAdoo added, “I am very excited to join this great team and play a significant role in further leveraging DSG™ technology to drive additional growth. I believe it represents a unique differentiating factor in the market and look forward to working with SpineGuard’s team, its customers and partners in the mission of making spine surgery safer.”
Previous press releases:
SpineGuard reports 2015 revenue growth of 43% to € 6.3M, on January 14, 2016.
SpineGuard secures € 7.7M debt financing with Bpifrance and IPF Partners, on January 11, 2016.
CE mark and world’s first spinal fusion surgery performed with single-step insertion of DSG™ Technology enabled screws, on January 5, 2016.
Next financial press release: 2015 annual results, on March 23, 2016.
SpineGuard will participate to the 'Invest Securities Biomed Event' on January 27 in Paris.
Co-founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard’s mission is to make spine surgery safer. Its primary objective is to establish its proprietary DSG™ (Dynamic Surgical Guidance) technology as the global standard of surgical care, initially for safer screw placement in spine surgery and then in other surgeries. PediGuard®, the first device designed using DSG was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. It is the world’s first and only handheld device capable of alerting surgeons to potential pedicular or vertebral breaches. Over 40,000 surgical procedures have been performed worldwide with PediGuard. Numerous studies published in peer-reviewed medical and scientific journals have demonstrated the multiple benefits that PediGuard delivers to patients, surgical staff and hospitals. In 2015, SpineGuard started to expand the applications of DSG into pedicle screws through partnerships with innovative surgical companies in France and the US. SpineGuard has offices in San Francisco and Paris. For further information, visit www.spineguard.com.
The SpineGuard securities may not be offered or sold in the United States as they have not been and will not be registered under the Securities Act or any United States state securities laws, and SpineGuard does not intend to make a public offer of its securities in the United States. This is an announcement and not a prospectus, and the information contained herein does and shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities referred to herein in the United States in which such offer, solicitation or sale would be unlawful prior to registration or exemption from registration.